Nov 02, 2015
3:1
For every share held, investors received 3. The price per share adjusted from $42.39 to $14.13.
The split itself did not change the total investment value.
Biotest AG (BIESF) trades on the Other OTC in the Biotechnology industry.
Biotest AG company overviewThe latest split shown was on November 2, 2015. It was a 3-for-1 forward split, so shareholders received 3 shares for every share they held.
This history records 2 forward splits between July 15, 2015 and November 2, 2015.
Already premium?